Mefloquine
Lariam, Mefloquine (mefloquine) is a small molecule pharmaceutical. Mefloquine was first approved as Lariam on 1989-05-02. It is used to treat falciparum malaria, malaria, and vivax malaria in the USA. It is known to target adenosine receptor A1, adenosine receptor A2a, and purine nucleoside phosphorylase.
Trade Name | Lariam, Mefloquine |
---|---|
Common Name | Mefloquine |
Indication | falciparum malaria, malaria, vivax malaria |
Drug Class |